Cyclopropyl(4-(trifluoromethyl)phenyl)methanamine

Catalog No. :
ACXRMN408
CAS No. :
581812-93-3
Molecular Formula :
C11H12F3N
Molecular Weight :
215.22

IUPAC Name:cyclopropyl(4-(trifluoromethyl)phenyl)methanamine

Cyclopropyl(4-(trifluoromethyl)phenyl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$158.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameCyclopropyl(4-(trifluoromethyl)phenyl)methanamine
IUPAC Namecyclopropyl(4-(trifluoromethyl)phenyl)methanamine
MDL No.MFCD11848970
Molecular FormulaC11H12F3N
Molecular Weight215.22
SMILESNC(C1CC1)C2=CC=C(C(F)(F)F)C=C2
InChI KeyZQGDJHVPZJFVNX-UHFFFAOYSA-N
Synonym1-CYCLOPROPYL-1-(4-TRIFLUOROMETHYLPHENYL)METHYLAMINE;alpha-Cyclopropyl-4-trifluoroMethyl-benzylaMine;CYCLOPROPYL(4-(TRIFLUOROMETHYL)PHENYL)METHANAMINE;a-Cyclopropyl-4-trifluoromethyl-benzylamine;Benzenemethanamine, α-cyclopropyl-4-(trifluoromethyl)-;α-Cyclopropyl-4-(trifluoromethyl)benzenemethanamine
CAS No.581812-93-3
PubChem CID22337655

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACXRMN408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXRMN408 route product structure diagram
    ACXRMN408581812-93-3
Inquiry

2. ACXRMN408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXRMN408 route product structure diagram
    ACXRMN408581812-93-3
Inquiry

Comments (0)